ATE258802T1 - Verwendung von vitis vinifera extrakten phospholipid komplexen als antiatherosclerotische mitteln - Google Patents

Verwendung von vitis vinifera extrakten phospholipid komplexen als antiatherosclerotische mitteln

Info

Publication number
ATE258802T1
ATE258802T1 AT98959890T AT98959890T ATE258802T1 AT E258802 T1 ATE258802 T1 AT E258802T1 AT 98959890 T AT98959890 T AT 98959890T AT 98959890 T AT98959890 T AT 98959890T AT E258802 T1 ATE258802 T1 AT E258802T1
Authority
AT
Austria
Prior art keywords
phospholipide
complexes
vitis vinifera
antiatherosclerotic agents
vinifera extracts
Prior art date
Application number
AT98959890T
Other languages
English (en)
Inventor
Paolo Morazzoni
Ezio Bombardelli
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Application granted granted Critical
Publication of ATE258802T1 publication Critical patent/ATE258802T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00—Technologies for the production of fuel of non-fossil origin
    • Y02E50/30—Fuel from waste, e.g. synthetic alcohol or diesel

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Solid Fuels And Fuel-Associated Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT98959890T 1997-12-04 1998-11-30 Verwendung von vitis vinifera extrakten phospholipid komplexen als antiatherosclerotische mitteln ATE258802T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97MI002690A IT1296920B1 (it) 1997-12-04 1997-12-04 Uso di complessi di estratti vitis vinifera con fosfolipidi come agenti anti-aterosclerotici
PCT/EP1998/007662 WO1999029331A1 (en) 1997-12-04 1998-11-30 The use of phospholipid complexes of extracts of vitis vinifera as anti-atherosclerotic agents

Publications (1)

Publication Number Publication Date
ATE258802T1 true ATE258802T1 (de) 2004-02-15

Family

ID=11378312

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98959890T ATE258802T1 (de) 1997-12-04 1998-11-30 Verwendung von vitis vinifera extrakten phospholipid komplexen als antiatherosclerotische mitteln

Country Status (23)

Country Link
US (1) US6297218B1 (de)
EP (1) EP1035859B1 (de)
JP (1) JP4456267B2 (de)
KR (1) KR100567867B1 (de)
CN (1) CN1126564C (de)
AT (1) ATE258802T1 (de)
AU (1) AU743031B2 (de)
BR (1) BR9805813B1 (de)
CA (1) CA2312795C (de)
CZ (1) CZ299555B6 (de)
DE (1) DE69821524T2 (de)
DK (1) DK1035859T3 (de)
ES (1) ES2214755T3 (de)
HK (1) HK1033267A1 (de)
HU (1) HU228109B1 (de)
IT (1) IT1296920B1 (de)
NO (1) NO324796B1 (de)
PL (1) PL191023B1 (de)
PT (1) PT1035859E (de)
RU (1) RU2207866C2 (de)
SI (1) SI1035859T1 (de)
SK (1) SK284865B6 (de)
WO (1) WO1999029331A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1304183B1 (it) * 1998-12-18 2001-03-08 Indena Spa Complessi di proantocianidina a2 con fosfolipidi come agentiantiaterosclerotici.
JP2001122791A (ja) 1999-10-20 2001-05-08 Boehringer Ingelheim Internatl Gmbh 下肢の慢性静脈不全の軽減および予防のための赤色ブドウ樹葉の水性抽出物よりなる食事補強剤
JP4574788B2 (ja) * 2000-03-24 2010-11-04 協和発酵バイオ株式会社 プロアントシアニジン含有組成物
IT1320080B1 (it) * 2000-10-25 2003-11-18 Giuliani Spa Composizione per uso farmaceutico o dietetico.
FR2836337B1 (fr) * 2002-02-28 2004-11-19 Bio Serae Laboratoires Utilisation des polymeres procyanidoliques a titre d'agents inhibuteurs des alpha-amylases et application dans des compositions a visees dietetiques
US20040151769A1 (en) * 2002-12-31 2004-08-05 Boehringer Ingelheim International Gmbh Film coated tablet containing an extract of red vine leaves
BRPI0317883B8 (pt) * 2002-12-31 2021-05-25 Boehringer Ingelheim Int comprimido revestido com filme compreendendo um extrato de folhas de vinha vermelha
ITMI20031313A1 (it) * 2003-06-27 2004-12-28 Indena Spa Associazioni di agenti vasoprotettori e formulazioni che li contengono.
EP1550450A1 (de) * 2003-12-29 2005-07-06 Boehringer Ingelheim International GmbH Behandlung von chronischer venöser Insuffizienz mit einem Extrakt aus Blättern von roten Weinreben und einem Blutumlauf verbesserndes Mittel
RU2367464C2 (ru) 2004-02-19 2009-09-20 Берингер Ингельхайм Интернациональ Гмбх Состав для лечения хронических венозных недостаточностей, содержащий водный экстракт листьев красного винограда и противовоспалительное средство
US20060088617A1 (en) * 2004-10-23 2006-04-27 Mccurry James M Chocolate composition and method for benefiting the cardiovascular system
AT501682A1 (de) 2005-01-14 2006-10-15 Hermine Dr Engl Verfahren zur herstellung einer wirkstoffmischung
EP1837030A1 (de) 2006-03-09 2007-09-26 INDENA S.p.A. Curcumin-phospholipid-Komplexe mit verbesserter Bioverfügbarkeit
EP2829277A1 (de) 2013-07-26 2015-01-28 Natac Biotech, S.L. Verwendung von A-Typ-Proanthocyanidinen bei der Behandlung einer Erkrankung in Zusammenhang mit dem Mineralocorticoidrezeptor
AU2018360383A1 (en) 2017-11-02 2020-05-21 Natureceuticals Sdn. Bhd. Extract of orthosiphon stamineus, formulations, and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2092743A1 (en) * 1970-06-15 1972-01-28 Aquitaine Invest Pharma Complete extraction of total flavanol gomers from plats -peripheral - venous activity
GB1541469A (en) * 1976-12-01 1979-02-28 Inverni Della Beffa Spa Method of obtaining flavonolic oligomers
IT1201151B (it) * 1987-01-14 1989-01-27 Indena Spa Complessi fosfolipidici con estratti da vitis vinifera,procedimento per la loro preparazione e composizioni che li cntengono
US5484594A (en) * 1988-06-28 1996-01-16 Tecnofarmaci S.P.A. Process for preparing grapeseed extracts enriched in procyanidol oligomers
FI955691A (fi) * 1994-11-28 1996-05-29 Suntory Ltd Lipoproteiini(a):ta alentava aine, kolesterolia alentava aine ja näitä aineita sisältävät lääkkeet

Also Published As

Publication number Publication date
ES2214755T3 (es) 2004-09-16
NO324796B1 (no) 2007-12-10
IT1296920B1 (it) 1999-08-03
PL340884A1 (en) 2001-03-12
EP1035859B1 (de) 2004-02-04
AU1562799A (en) 1999-06-28
WO1999029331A1 (en) 1999-06-17
CA2312795A1 (en) 1999-06-17
CZ299555B6 (cs) 2008-09-03
SI1035859T1 (en) 2004-04-30
PL191023B1 (pl) 2006-03-31
CN1126564C (zh) 2003-11-05
SK284865B6 (sk) 2006-01-05
US6297218B1 (en) 2001-10-02
DE69821524D1 (de) 2004-03-11
CN1280498A (zh) 2001-01-17
SK8272000A3 (en) 2000-11-07
RU2207866C2 (ru) 2003-07-10
CA2312795C (en) 2009-01-20
BR9805813A (pt) 1999-12-14
HUP0100522A3 (en) 2002-04-29
EP1035859A1 (de) 2000-09-20
JP4456267B2 (ja) 2010-04-28
HUP0100522A2 (hu) 2001-12-28
DK1035859T3 (da) 2004-05-17
CZ20002038A3 (cs) 2000-12-13
HK1033267A1 (en) 2001-08-24
KR100567867B1 (ko) 2006-04-04
DE69821524T2 (de) 2005-01-05
KR20010024654A (ko) 2001-03-26
JP2001525370A (ja) 2001-12-11
AU743031B2 (en) 2002-01-17
NO20002827L (no) 2000-06-02
PT1035859E (pt) 2004-05-31
HU228109B1 (en) 2012-11-28
ITMI972690A1 (it) 1999-06-04
BR9805813B1 (pt) 2009-05-05
NO20002827D0 (no) 2000-06-02

Similar Documents

Publication Publication Date Title
ATE258802T1 (de) Verwendung von vitis vinifera extrakten phospholipid komplexen als antiatherosclerotische mitteln
DE69617469D1 (de) Behandlung von multipler sklerose
ATE181231T1 (de) Verfahren zur hautpflege und mittel
ES2189235T3 (es) 6-fenilfenantridinas sustituidas.
EA200100572A1 (ru) Способ применения ингибитора циклооксигеназы-2 и одного или нескольких противоопухолевых лекарственных средств в качестве комбинированного способа лечебного воздействия при лечении неоплазии
TR200100047T2 (tr) Tiyobenzimidazol türevleri
PT950057E (pt) Enantiomeros de 3-piridilo e sua utilizacao como analgesicos
TR199800815A2 (en) S�lfonilaminokarbonasitler.
PT1131039E (pt) Utilizacao de uma substancia que se liga ao receptor periferico das benzodiazepinas no tratamento de stresses cutaneos
BR0212252A (pt) Métodos para reduzir a hipertensão e a insuficiência cardìaca em um mamìfero
TR199801302T2 (xx) �kame edilmi� aza ve diazasikolopentan ve siklooktan bile�ikleri.
DE69822496D1 (de) Lipidkomplex-lyophilisat von wasserunlöslichen porphyrinen
NO912435D0 (no) Farmasoeytiske preparater.
ATE238803T1 (de) Pphospholipidkomplexe von proanthocyanidin a2 als antiatherosklerotische mittel
DE69526350D1 (de) Abschuppungs-zusammensetzung
ATE293972T1 (de) Behandlung von chronischen schmerzen
PT751775E (pt) Derivados de mercaptoacetilamida hipocolesterolemicos, antiateroscleroticos e hipotrigliceridemicos
ATE306269T1 (de) Behandlung der exzessiven aggressivität mit olanzapine
FI965171A0 (fi) Oksatsofosforiinien, esimerkiksi ifosfamidin, enantiomeerien käyttö kasvainten hoidossa sivuvaikutuksien vähentämiseksi
ATE214923T1 (de) Verwendung von (r)-verapamil als medizin zur behandlung von angina
BR7501580U (pt) Disposição construtiva aplicada em pote liquido emoliente de cuticulas

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1035859

Country of ref document: EP